PROGRAM - DAY 1

THURSDAY 26 NOVEMBER 2026

Challenges and New Approaches in GIST Management (Debulking, Multimodality Therapy, Unresectable Disease Becomes Resectable)

Room: Federation Concert Hall
Chairs: TBA

Perioperative therapies in Oesophagogastric Adenocarcinoma: Achievements and the Path Ahead Oncology visitor
The evolving role of Radiotherapy in Oesophagogastric Adenocarcinoma: Standard, Selective, or Sunset? Trevor Leong – Include TOPGEAR and learnings from TOPGEAR
Surgical status 2026 – multimodality management of oesophageal adenocarcinoma and how surgery is finding a new role Surgical Visitor
Impact of nutritional status on oncological outcomes: How can we improve collaboration Lisa Murnane

Room: Federation Ballroom

Controversies and Debates: Evolving Perspectives and Emerging Consensus
Room: Federation Concert Hall
Chairs: TBA

Can tailored or radical surgery make a crucial difference or is the die already cast by response to therapy?Quality of surgery, and variation in practice - Surgical Speaker
The oligometastatic frontier: Defining “resectable stage IV” Surgical Speaker
MDT case of oligometastatic diseaseTBA
Peritoneal relapse in OG adenocarcinoma: OMECGA update, Are peritoneal-directed therapies ready for prime time?TBA
Opportunities for AANZGOSA CTG Research
a. Opportunities for GCT to interface with AANZGOSA – (CTG presenter)
b. AANZGOSA research sub-committee – can this help the interface
a. CTG Presenter
Panel discussion: Opportunities and potential trialsProf. Niall Tebbutt, Melbourne, Australia

Room: Federation Ballroom

New Opportunities for Addressing Old Problems
Room: Federation Concert Hall
Chairs: TBA

Immunotherapeutic Opportunities in dMMR Oesophagostric Adenocarcinoma Oncology Visitor
IO – the Australian perspectiveTBA
When immunotherapy reshapes the surgical battlefield: how and when to survey, modalities of response, when has a cCR been achieved?TBA
Role of RTx and abscopal response TBA
MDT case/Panel discussion

Room: Federation Ballroom

Super MDT: Where guidelines meet reality
Room: Federation Concert Hall
Chairs: TBA

SqCC – CRT, role of consolidation CRT, role of salvage surgeryTBA
Managing unresectable stage 3 diseaseTBA
Stage IV with “extreme” response to inductionTBA

Lumina (Part of the Tasman Hotel)
12 Murray Street, Hobart
Purchase a Dinner Ticket HERE

PROGRAM - DAY 2

FRIDAY 27 NOVEMBER 2026

Technical Precision the Challenging Oesophageal Dissection Post Radiotherapy (visitor/1 ANZ speaker/moderator/panel)

Keynote introduction invited visitor surgical visitor: Translational research and its role in OG surgeryTBA
Key note oncology visitor: Neo-adjuvant therapy gastric cancer – immunotherapy and new directions TBA
Volume performance relationship in ANZ: Have we improved and what should service delivery look likeTBA
Medical oncology centralised versus regional careTBA
Delivering nutritional care and prehabilitation equitably what is the minimum standard of care? TBA

Looking to the Future

Beyond the FLOT vs. CROSS Stalemate: trial data, real-world evidence and future directionsTBA - Med Oncologist
Where will be in 2030 and beyond in surgery for OG malignancy? TBA
The patient who is physiological ‘borderline’ for surgery what to do. What if they improve during treatment? TBA
Down staged disease what to do when does stage IV disease become resectable?TBA
Credentialing for OG resections in ANZ what should it look like does AANZGOSA have a role to play
TBA

Integrated Health

TBA
TBA
TBA
TBA
TBA

Complex Issues

Key note lecture: Neuroendocrine tumours of the Upper GI tract TBA
Key note lecture: Radical gastrectomy and what is XTG and how to do it?TBA
Imaging in OG malignancy and staging: What is the latest and newestTBA
Prehabilitation versus ERAS what is more important? TBA
Patient and carer unmet needsTBA

AANZGOSA Free Papers

Collaboration Research and Multidisciplinary Care

Part 1 - Complex gastric MDM – difficult cases
e.g. Functional problems
TBA
Gastroparesis TBA
Post bariatric surgery functional issues TBA

We gratefully acknowledge our sponsors BRONZE BRONZE BRONZE PLATINUM